TY  - GEN
AU  - Rohlenova,Katerina
AU  - Sachaphibulkij,Karishma
AU  - Stursa,Jan
AU  - Bezawork-Geleta,Ayenachew
AU  - Blecha,Jan
AU  - Endaya,Berwini
AU  - Werner,Lukas
AU  - Cerny,Jiri
AU  - Zobalova,Renata
AU  - Goodwin,Jacob
AU  - Spacek,Tomas
AU  - Alizadeh Pesdar,Elham
AU  - Yan,Bing
AU  - Nguyen,Maria Nga
AU  - Vondrusova,Magdalena
AU  - Sobol,Margaryta
AU  - Jezek,Petr
AU  - Hozak,Pavel
AU  - Truksa,Jaroslav
AU  - Rohlena,Jakub
AU  - Dong,Lan-Feng
AU  - Neuzil,Jiri
TI  - Selective Disruption of Respiratory Supercomplexes as a New Strategy to Suppress Her2
SN  - 1557-7716
PY  - 2017///0810
KW  - Antineoplastic Agents
KW  - chemistry
KW  - Biomarkers
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Cell Death
KW  - drug effects
KW  - Cell Line, Tumor
KW  - Cell Respiration
KW  - Electron Transport Chain Complex Proteins
KW  - antagonists & inhibitors
KW  - Electron Transport Complex I
KW  - Female
KW  - Humans
KW  - Inhibitory Concentration 50
KW  - Membrane Potential, Mitochondrial
KW  - Mitochondria
KW  - Models, Molecular
KW  - Molecular Conformation
KW  - Molecular Targeted Therapy
KW  - Protein Binding
KW  - Reactive Oxygen Species
KW  - metabolism
KW  - Receptor, ErbB-2
KW  - Tamoxifen
KW  - pharmacology
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1089/ars.2016.6677
ER  -